Epstein M, Weitzman R E, Preston S, DeNunzio A G
Miner Electrolyte Metab. 1984;10(3):155-65.
Although an impairment in renal water excretion is a commonly encountered clinical problem in cirrhotic patients, the mechanisms responsible for this abnormality are uncertain. ADH levels are elevated in some patients with decompensated cirrhosis, but a causal relationship between these levels and impaired water excretion has not been established. Since in normal man, water immersion to the neck (NI) results in a preferential central hypervolemia (CV), without plasma compositional change, and a resultant suppression of AVP, we designed the present study to determine if the diuretic response of cirrhotic patients to NI is mediated by a decrease in AVP. 17 cirrhotic patients with ascites were studied following 14 h of dehydration on two occasions: during a seated control study (C) and during 4 h of NI. AVP, determined by RIA, was measured every 30 min. 12 of the 17 patients manifested a diuresis that equalled or exceeded that documented in normal hydropenic subjects during immersion. NI did not alter mean AVP as compared with either the pre-study hour or those of the corresponding control study. Furthermore, peak V and CH2O varied independently of prestudy AVP (r = -0.116), mean change in AVP (r = -0.060), as well as nadir AVP levels (r = -0.122). The demonstration of a diuresis in some of the subjects, occurring without concomitant suppression of plasma AVP, suggests that ADH may constitute a permissive rather than pivotal factor in the impaired water excretion of many patients with advanced liver disease.
尽管肾排水功能受损是肝硬化患者常见的临床问题,但导致这种异常的机制尚不清楚。在一些失代偿期肝硬化患者中,抗利尿激素(ADH)水平升高,但这些水平与排水功能受损之间的因果关系尚未确立。由于在正常人中,颈部浸入水中(NI)会导致优先的中心血容量过多(CV),而血浆成分无变化,并导致抗利尿激素(AVP)分泌受抑制,我们设计了本研究以确定肝硬化患者对NI的利尿反应是否由AVP降低介导。17例有腹水的肝硬化患者在两次脱水14小时后进行研究:一次是坐位对照研究(C),另一次是4小时的NI研究。通过放射免疫分析(RIA)测定AVP,每30分钟测量一次。17例患者中有12例表现出的利尿作用等于或超过正常禁水受试者在浸入水中时记录的利尿作用。与研究前一小时或相应对照研究相比,NI并未改变平均AVP。此外,峰值V和水清除率(CH2O)的变化与研究前AVP(r = -0.116)、AVP的平均变化(r = -0.060)以及AVP最低水平(r = -0.122)无关。一些受试者出现利尿作用而血浆AVP未同时受抑制,这表明在许多晚期肝病患者的排水功能受损中,ADH可能是一个允许性而非关键因素。